Actively Recruiting

Early Phase 1
Age: 55Years - 85Years
All Genders
NCT04740580

Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease

Led by Baylor College of Medicine · Updated on 2025-06-10

52

Participants Needed

1

Research Sites

254 weeks

Total Duration

On this page

Sponsors

B

Baylor College of Medicine

Lead Sponsor

T

The Methodist Hospital Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

Alzheimer's disease (AD) is associated with significant, progressive cognitive decline. Key defects in mitochondrial fuel metabolism insulin resistance, inflammation and decreased brain glucose uptake are linked to AD. This trial will investigate the effects of supplementing glycine and N-acetylcysteine vs. alanine as placebo on these defects in AD, and examine the effects on cognition.

CONDITIONS

Official Title

Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease

Who Can Participate

Age: 55Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 55-85 years
  • Gradual and progressive memory loss for more than 1 year with a Montreal Cognitive Assessment score of 10-20
  • Amyloid positivity on PET scan
  • Availability of a study partner
Not Eligible

You will not qualify if you...

  • Hospitalization in past 3 months
  • Use of insulin medications
  • Untreated thyroid disease
  • Creatinine levels greater than 1.5 mg/dL
  • Hemoglobin concentration less than 11.0 g/dL
  • Known liver disease or AST/ALT level greater than 2 times upper limit of normal
  • History of stroke, brain tumor, active heart failure, or active cancer (except removable basal cell cancers)
  • Untreated depression or other severe psychiatric disorders
  • Pregnancy or nursing (unlikely in this population)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Baylor College of Medicine

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

R

Rajagopal V Sekhar, M.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here